In the MDA-MB-231 metastatic breast cancer cell line, treatment with RQC or resveratrol at concentrations >3 μM, inhibited Akt activity by ~50%, while catechin alone reduced Akt activity by ~40% at 15μM. The gene discussed is AKT1; the disease is breast carcinoma.